| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
NeuroOne Medical Tech (NASDAQ:NMTC) reported its Q3 earnings results on Thursday, August 11, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
NeuroOne Medical Tech beat estimated earnings by 22.73%, reporting an EPS of $-0.17 versus an estimate of $-0.22.
Revenue was down $8 thousand from the same period last year.
Last quarter the company beat on EPS by $0.01 which was followed by a 1.74% drop in the share price the next day.
To track all earnings releases for NeuroOne Medical Tech visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: NMTC
